No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
scientific article published in May 2015
Instance of
Author
Alison Dunning
Graham Giles
Pierre Laurent-Puig
Veli-Matti Kosma
Arja Jukkola-Vuorinen
Vesa Kataja
Arto Mannermaa
Pascal Guénel
Dieter Flesch-Janys
Katri PylkÀs
ThérÚse Truong
Montserrat GarcĂa-Closas
Kristiina AittomÀki
Robert Winqvist
Antoinette Hollestelle
Andreas Schneeweiss
Kamila Czene
Georgia Chenevix-Trench
Vessela Kristensen
Florence Menegaux
Peter Devilee
Paolo Peterlongo
Barbara Burwinkel
Kunle Odunsi
Agnieszka Dansonka-Mieszkowska
Camilla Krakstad
Angela Brooks-Wilson
Joanna Plisiecka-Halasa
Irene Konstantopoulou
Sandrina Lambrechts
Amanda Ewart Toland
Jolanta Kupryjanczyk
Daphne Gschwantler-Kaulich
Els Van Nieuwenhuysen
Ramunas Janavicius
Hiltrud Brauch
Loic Le Marchand
Cezary Cybulski
Australian Ovarian Cancer Study Group
Anne-Marie Gerdes
BĂžrge G. Nordestgaard
Adriana Lasa
Liisa Pelttari
Rosalind Glasspool
Benoit Beuselinck
Atocha Romero
Daniel Barrowdale
Judith S Brand
Mikael Eriksson
Hans Ehrencrona